WO2015098959A1 - Sample disruption method, biomolecule extraction method, and disruption solution containing nanowires - Google Patents
Sample disruption method, biomolecule extraction method, and disruption solution containing nanowires Download PDFInfo
- Publication number
- WO2015098959A1 WO2015098959A1 PCT/JP2014/084139 JP2014084139W WO2015098959A1 WO 2015098959 A1 WO2015098959 A1 WO 2015098959A1 JP 2014084139 W JP2014084139 W JP 2014084139W WO 2015098959 A1 WO2015098959 A1 WO 2015098959A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nanowire
- sample
- cells
- disruption
- nanowires
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
- G01N2001/2866—Grinding or homogeneising
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/38—Diluting, dispersing or mixing samples
- G01N2001/386—Other diluting or mixing processes
Definitions
- the present invention relates to a sample crushing method, a biomolecule extraction method, and a crushing liquid containing nanowires.
- a sample of cells, viruses, bacteria, etc. hereinafter sometimes referred to as “cells”
- a disruption solution containing nanowires hereinafter also simply referred to as “disruption solution”.
- DNA and RNA may also be referred to as “nucleic acid”.
- the present invention relates to a sample crushing method, a biomolecule extraction method, and a crushing liquid containing nanowires, which can recover biomolecules such as proteins.
- kits for this purpose are also commercially available from several companies, and biomolecules can be extracted from cells and the like relatively easily.
- the above-mentioned kit for crushing cells and the like to extract biomolecules contains reagents such as phenol, chloroform and surfactant, and these reagents denature the biomolecules after crushing and extraction. It is known that the analysis may be adversely affected (see Non-Patent Documents 1, 2, and 3).
- Non-Patent Document 3 As a method for disrupting cells and the like without using a reagent, a method is known in which cells and the like are disrupted by moving the cells or the like so as to rub against a nanowire provided on a substrate (see Non-Patent Document 3). .
- All of the methods described in Non-Patent Document 3 are obtained by growing nanowires in microchannels provided on a substrate. Therefore, since the amount of cells and the like that can be crushed is limited by the size of the microchannel and the flow rate per unit time, there is a problem that the crushing efficiency is poor.
- the invention described in Non-Patent Document 3 is an invention in which cells and the like are crushed when passing through the nanowire bundles grown in the microchannel at a flow rate of a predetermined level or more.
- the interval between them is constant. Therefore, for example, if the interval between the nanowire bundles is narrowed, clogging is likely to occur when the cells to be crushed are large, and conversely, if the interval between the nanowire bundles is widened, the nanowire bundles when the cells to be crushed are small. It passes between and becomes difficult to crush. For this reason, it is necessary to prepare chips with different intervals between nanowire bundles according to the size of cells to be crushed, which is inefficient. Furthermore, since the invention described in Non-Patent Document 3 grows nanowires in the microchannel, the surface of the grown nanowires is extracted from the target biological components after crushing cells or the like. There is a problem that it is difficult to apply.
- the present invention is an invention made to solve the above-mentioned conventional problems, and as a result of extensive research, a sample such as a cell is suspended in a disruption solution containing nanowires, and then a disruption solution in which the sample is suspended is obtained. It was newly found that, by stirring, cells and the like can be efficiently disrupted without using a reagent or the like. Furthermore, it has been newly found that biomolecules such as DNA, RNA, and protein can be extracted with high purity by using nanowires in which one or two selected from proteolytic enzymes, ribonucleases, and deoxyribonucleases are immobilized. The present invention has been completed.
- the object of the present invention is to provide a method for crushing a sample using nanowires, a method for extracting biomolecules, and a crushing liquid containing nanowires.
- the present invention relates to a sample disruption method using nanowires, a biomolecule extraction method, and a disruption solution containing nanowires, as described below.
- a sample disruption solution selected from cells, viruses, and fungi containing nanowires selected from cells, viruses, and fungi containing nanowires.
- the sample can be crushed with the crushing liquid containing nanowires, it is not necessary to use a reagent or the like when crushing the sample. Therefore, biomolecules such as nucleic acids and proteins that leak into the crushing liquid after crushing the sample are not denatured, and there is no possibility that the analysis of the extracted biomolecules may be adversely affected or can be reduced.
- the sample is crushed by suspending and stirring the sample in a crushing liquid containing nanowires. Therefore, there is no limitation on the capacity and flow rate of the micro-channel as in the prior art, and all the nanowires contained in the disruption liquid contribute to the disruption of the sample. It can be crushed.
- the nanowires are stirred in the crushing liquid in a dispersed state, there is no risk of clogging due to the residue of the sample after crushing or it can be reduced.
- nanowires on which one or two selected from proteolytic enzymes, ribonucleases, and deoxyribonucleases are immobilized can be dispersed. Therefore, the target biomolecule can be recovered with high purity.
- FIG. 1 is a diagram showing an example of a procedure for producing nanowires 4 used in the crushing liquid of the present invention.
- FIG. 2 is a drawing-substituting photograph, which is a field emission scanning electron microscope (FESEM) photograph of the nanowire 4 grown on the substrate 1.
- FIG. 3 is a graph showing that there is a correlation between the concentration of nanowires and absorbance in phosphate buffered saline (PBS).
- FIG. 4 is a graph showing the relationship between the stirring time and the number of cycles in Example 2 and Comparative Examples 3 to 5.
- FIG. 5 is a graph showing the relationship between the stirring time and the number of cycles in Example 3 and Comparative Examples 6 and 7.
- FIG. 6 is a graph showing the relationship between the stirring time and the number of cycles in Example 4, Comparative Examples 8 and 9, and Comparative Example 4 in which cells and the like were chemically disrupted.
- FIG. 7 is a graph showing the relationship between the stirring time of Example 5 and Comparative Examples 10 to 12 and the number of cycles.
- FIG. 8 is a chart showing the analysis results of Example 7 and Reference Example 1.
- FIG. 9 is a drawing-substituting photograph, (1) is Example 10, (2) is Example 11, and (3) is a scanning electron microscope (SEM) photograph at the end of stirring in Comparative Example 13. is there.
- FIG. 10 is a graph showing the DNA concentration in the suspensions of Examples 10 and 11 and Comparative Example 13.
- the crushing liquid containing the nanowire of the present invention can be prepared by dispersing the nanowire in a dispersion liquid.
- the “nanowire” in the present invention is not particularly limited in terms of production method, size, material, etc., as long as it can be crushed by damaging cells and the like when dispersed in a dispersion and stirred with cells and the like. .
- FIG. 1 is a diagram showing an example of a procedure for producing nanowires used in the crushed liquid of the present invention.
- Nanowires can be produced by the following procedure. (1) The substrate 1 is prepared. (2) The nanowire-producing particles 2 or the catalyst 3 are applied on the substrate 1. (3) The nanowire 4 is grown on the substrate 1. (4) The nanowire 4 is peeled from the substrate 1 by running water treatment or ultrasonic treatment. (5) The separated nanowire 4 is washed and centrifuged. (6) The separated nanowire 4 is put in a container 5 such as an Eppendorf tube and dispersed in the dispersion liquid 6 to prepare a crushed liquid.
- a container 5 such as an Eppendorf tube and dispersed in the dispersion liquid 6 to prepare a crushed liquid.
- the material of the substrate 1 is PDMS (poly (siloxane siloxane)), PMMA (poly (methyl methacrylate)), PC (polycarbonate), plastic made of hard polyethylene, etc., as long as the nanowire 4 can be grown.
- PDMS poly (siloxane siloxane)
- PMMA poly (methyl methacrylate)
- PC polycarbonate
- plastic made of hard polyethylene etc.
- Examples of the particles 2 for producing the nanowire 4 include ZnO.
- the nanowire 4 using ZnO fine particles can be produced using the hydrothermal synthesis method described in Non-Patent Document 3. Specifically, first, ZnO particles are applied on the substrate 1. Next, the heated substrate 1 is immersed in a precursor solution in which zinc nitrate hexahydrate (Zn (NO 3 ) 2 .6H 2 O) and hexamethylenetetramine (C 6 H 12 N 4 ) are dissolved in deionized water. By doing so, the ZnO nanowire 4 can be grown.
- ZnO particles zinc nitrate hexahydrate
- C 6 H 12 N 4 hexamethylenetetramine
- Examples of the catalyst 3 for producing the nanowire 4 include gold, platinum, aluminum, copper, iron, cobalt, silver, tin, indium, zinc, and gallium.
- the nanowire 4 using the catalyst 3 can be produced by the following procedure.
- (A) The catalyst 3 is deposited on the substrate 1.
- a material such as SnO 2 , Sm 2 O 3 , or EuO, a core nanowire is formed by physical vapor deposition such as pulse laser deposition or VLS (Vapor-Liquid-Solid).
- a coating layer is formed around the core nanowire by a general vapor deposition method such as Deposition).
- the nanowire 4 produced using the catalyst 3 may be a nanowire 4 having no branched chain, or may be a nanowire 4 having a branched chain.
- the diameter of the nanowire 4 is not particularly limited as long as it is a size that can damage and crush cells by stirring as described above. However, the size of the cell, virus, fungus, etc. that is the purpose of crushing, cell membrane or You may change according to the intensity
- the diameter of the nanowire 4 needs to be smaller than that of the cell or the like that is to be crushed, and is, for example, 200 nm or less, 150 nm or less, 100 nm or less, 90 nm or less, 80 nm or less, 70 nm or less, 60 nm or less, or 50 nm or less. May be.
- the diameter of the nanowire 4 can be appropriately adjusted by changing the size of the particle 2 or forming a coating layer on the produced nanowire 4 when the particle is formed using the particle 2.
- the coating layer may be formed with the same material and coating method as the coating layer when the catalyst 3 is used, and the deposition time may be adjusted as appropriate.
- a diameter can be suitably adjusted by changing the vapor deposition time at the time of forming a coating layer.
- the nanowires 4 and the cells that are released are agitated and the nanowires 4 come into contact with the cells or the like, the nanowires 4 damage the cells or the like due to the inertial force in the length direction due to the difference in aspect ratio.
- the length of the nanowire 4 is not particularly limited as long as it is a length capable of damaging cells and the like by crushing, but is preferably 300 nm or more. If it is smaller than 300 nm, it is not substantially different from the particle 2 and it is not preferable because it is difficult to damage because of its short length even when it comes into contact with a cell or the like.
- the length of the nanowire 4 is longer than the size of a cell or the like to be crushed, the probability of contact is reduced and the nanowires 4 are easily entangled with each other.
- the length of the nanowire 4 can be adjusted by changing the immersion time in the precursor solution when formed using the particles 2.
- the length of the nanowire 4 can be suitably adjusted by changing the growth time by VLS after forming a core nanowire.
- the nanowires 4 grown on the substrate 1 can be peeled off from the substrate 1 by running water treatment, but if necessary, the nanowires 4 are peeled off from the substrate 1 by immersing the substrate 1 in the dispersion 6 and performing ultrasonic treatment. May be.
- the ultrasonic treatment may be performed for about several minutes using a commercially available general ultrasonic treatment apparatus.
- the crushing liquid of the present invention can be produced by adding nanowires 4 peeled from the substrate 1 to the dispersion liquid 6 and dispersing the aggregated nanowires 4 by ultrasonic treatment.
- the concentration of the nanowire 4 in the crushed liquid may be adjusted as appropriate according to the concentration of cells and the like, and the concentration may be adjusted so that the absorbance of the spectrophotometer becomes a desired value.
- the dispersion 6 of the nanowire 4 has no particular problem as long as it is a liquid that does not denature biomolecules such as nucleic acids and proteins or does not affect the subsequent analysis.
- phosphate buffered saline (PBS) or the like can be used.
- a buffer solution may be mentioned.
- the collected nanowires 4 may be dispersed in the dispersion 6 as they are, but may be dispersed in the dispersion 6 after the nanowires 4 are treated.
- proteolytic enzymes such as Protease K, endopeptidase, and exopeptidase are immobilized around the recovered nanowires 4 so that the disruption solution and cells, etc. You may enable it to decompose
- the proteolytic enzyme can be fixed to the nanowire 4 by suspending the nanowire 4 collected in a solution containing the proteolytic enzyme and leaving it for a predetermined time, followed by washing with distilled water or the like.
- nucleic acid-degrading enzymes RNase A, RNase L, etc., which degrade RNA, deoxygenases, such as DNase I, DNase II, etc., which degrade DNA, are collected around the collected nanowires 4.
- deoxygenases such as DNase I, DNase II, etc.
- the nucleolytic enzyme can be fixed to the nanowire 4 by suspending the collected nanowire 4 in a solution containing the nucleolytic enzyme and leaving it for a predetermined time, and then washing with distilled water or the like.
- the above proteolytic enzyme and nucleolytic enzyme may be used in combination.
- a proteolytic enzyme and ribonuclease are immobilized on the nanowire 4
- a proteolytic enzyme and Deoxyribonuclease may be immobilized.
- the recovered nanowire 4 is suspended in a mixed solution of proteolytic enzyme and ribonuclease, or a mixed solution of proteolytic enzyme and deoxyribonuclease, and left for a predetermined time, and then washed with distilled water or the like. Can be fixed to the nanowire 4.
- sample means one that can recover internal biomolecules by crushing using a crushing solution, and examples thereof include cells, viruses, and fungi.
- the cells include those having a cell membrane structure, such as staphylococci, Bacillus subtilis, Escherichia coli, Salmonella, Pseudomonas aeruginosa, Vibrio cholerae, Shigella, Bacillus anthracis, tuberculosis, Clostridium botulinum, tetanus, Examples include bacteria such as streptococci, granulocytes, lymphocytes, reticulocytes, erythrocytes, leukocytes, blood cells such as platelets, and the like.
- a cell membrane structure such as staphylococci, Bacillus subtilis, Escherichia coli, Salmonella, Pseudomonas aeruginosa, Vibrio cholerae, Shigella, Bacillus anthracis, tuberculosis, Clostridium botulinum, tetanus
- bacteria such as streptococci, granulocytes, lymphocytes,
- viruses examples include norovirus, rotavirus, influenza virus, adenovirus, coronavirus, measles virus, rubella virus, hepatitis virus, herpes virus, HIV and the like.
- fungi examples include mushrooms, molds, and yeasts, and specifically include ringworm fungi, Candida, Aspergillus, and budding yeast. Mitochondria, exosomes and extracellular vesicles can also be mentioned as samples. Note that the sample is not limited to the above example as long as the material inside the sample can be recovered by crushing.
- the crushing of a sample such as a cell can be performed according to the procedure described below.
- a step of suspending cells collected by centrifugation or the like in a disruption solution to prepare a suspension is performed.
- the suspension may be prepared by putting it in a known container 5 such as an Eppendorf tube that does not easily affect biomolecules.
- a known container 5 such as an Eppendorf tube that does not easily affect biomolecules.
- concentration of nanowire 4 and the concentration of cells, etc. in the suspension are sufficiently agitated in the suspension in the agitation step, and the tip of nanowire 4 comes into contact with the cells, etc. If it is the density
- a step of stirring the suspension is performed.
- the stirring step is not particularly limited as long as the nanowire 4 and the cells can be stirred.
- the container 5 may be stirred using a vortex mixer, or a stirring bar of a magnetic stirrer may be placed in the container 5 and stirred.
- the stirring speed and time may be appropriately adjusted according to the concentration of the nanowire 4 and the type and concentration of the sample.
- the suspension residue removal step such as centrifugation is performed to precipitate and remove residues such as nanowires 4, unbroken cells, and cell walls in the suspension, and extract biomolecules. can do.
- the biomolecules leaked into the suspension during the stirring step are nanowires. Therefore, the desired biomolecule can be extracted with high purity. Furthermore, when the enzyme is immobilized on the nanowire 4, the enzyme can be simultaneously removed from the suspension by removing the nanowire 4 by centrifugation after the stirring step. Compared with the case of adding the enzyme, the enzyme that degrades the biomolecule can be easily removed.
- the enzymes may be added during the stirring step or after the stirring step. In that case, after degrading the biomolecule with the enzyme, the added enzyme may be removed from the suspension according to a conventional method.
- Example 1 A mixed solution in which NANOBYK (registered trademark) -3820 (produced by Big Chemie Japan Co., Ltd .; ZnO diameter: 20 nm) as ZnO particles was mixed with 5 mL and 1.35 mg (1 mmol / L) of 10-CDPA (Dojindo) as a crosslinker was mixed. And left at room temperature for 3 days. Thereafter, the mixed solution was diluted 10,000 times, and uniformly applied onto the substrate 1 (PMMA (poly (methymethacrylate), 50 mm ⁇ 50 mm) using a pipette, and fixed at 85 ° C. for 1 hour.
- PMMA poly (methymethacrylate), 50 mm ⁇ 50 mm
- the substrate 1 is treated with a phosphate buffered saline solution (PBS; 5 mL), and then the substrate 1 is immersed in the PBS, and an ultrasonic device (US-1, manufactured by Asone) is used.
- PBS phosphate buffered saline solution
- US-1 ultrasonic device
- the concentration of the nanowire 4 in the PBS solution is correlated with the absorbance, and the diameter of the prepared nanowire 4 was about 100 nm and the average length was 2 ⁇ m. 700 ⁇ L of the crushed liquid was collected in a tube to prepare the crushed liquid of Example 1.
- Example 1 In place of the nanowire 4 of Example 1, ZnO particles (by Big Chemie Japan Co., Ltd .; ZnO diameter: 20 nm) were used, and the crushing was performed in the same manner as in Example 1 except that the absorbance was 0.629 as in Example 1. A liquid was prepared.
- RNA extraction and quantification experiments were performed from Hela cells.
- Hela cells purchased from ECACC were used. Fetal Bovine Serum (FBS, Invitrogen) is warmed at 55 ° C., inactivated sufficiently for 30 minutes, added to Minimum Essential Medium Eagle (Sigma-Aldrich) so that the FBS capacity becomes 10%, and Penicillin ⁇ Streptomycin (manufactured by SIGMA) is 1%, L-GLUTAMINE (manufactured by SIGMA) is 1%, and 100X Non-Essential Amino Acids for MEM Eagle (manufactured by MP Biomedicals) is 1%. A culture medium was prepared.
- FBS Fetal Bovine Serum
- SIGMA Minimum Essential Medium Eagle
- L-GLUTAMINE manufactured by SIGMA
- 100X Non-Essential Amino Acids for MEM Eagle manufactured by MP Biomedicals
- sample adjustment 10 ⁇ L of the cell suspension was injected into C-Chip (Digital Bio) and the number of cells was counted using a microscope. Samples were prepared by diluting with a new medium so as to obtain the desired number of cells.
- RNA extraction / purification was performed using miRNeasy Mini from Qiagen according to the attached manual. First, 140 ⁇ L of chloroform (Infinity Pure, manufactured by Wako) was added to each suspension, stirred for 15 seconds, and allowed to stand at room temperature for 3 minutes.
- Centrifugation was performed for 15 minutes at 4 ° C. and 13,000 rpm using 5424R manufactured by Eppendorf, and then 350 ⁇ L of the upper layer was transferred to a 1.5 mL tube. 525 ⁇ L of ethanol (99.5%, Infinity Pure, manufactured by Wako) was added, and pipetting was performed several times. Next, 700 ⁇ L was transferred to a spin column, and centrifuged at 25 ° C., 10,300 rpm, 15 seconds. The filtrate was discarded, 700 ⁇ L of RWT was transferred to a spin column, centrifuged at room temperature, 10,300 rpm, 15 seconds, and the filtrate was similarly discarded.
- RNA [Quantification of RNA] RT-PCR was performed on each extracted RNA using a Transscriptor High Fidelity cDNA Synthesis Kit manufactured by Roche Applied Science. To 2 ⁇ L of RNA, 1 ⁇ L of anchor oligo primer and 8.4 ⁇ L of PCR grade water were added, left at 65 ° C. for 10 minutes, and stored at 4 ° C. Transscriptor High Fidelity Reverse Transscriptase Reaction Buffer 5X, 4 ⁇ L of Protector RNase Inhibitor, 0.5 ⁇ L of Protector RNase Inhibitor, 2 ⁇ L of deoxynucleotide Mix, 1 ⁇ L of DTT CDNA was prepared by treatment at 5 ° C. for 5 minutes and stored at 4 ° C.
- FIG. 4 is a graph showing the relationship between the stirring time of Example 2 and Comparative Examples 3 to 5 and the number of cycles.
- Comparative Example 5 in which Hela cells were chemically disrupted, the number of cycles was almost the same regardless of the stirring time.
- Example 2 using the crushed liquid in which the nanowires 4 were dispersed a great difference was not seen from Comparative Examples 3 and 4 until the stirring time was about 60 minutes, but as the stirring time was increased, the number of cycles was Obviously it became smaller. From the above results, it became clear that by using the disruption solution containing the nanowire 4 of the present invention, cells and the like can be disrupted and RNA can be extracted without using a chemical disruption solution. Moreover, it became clear that more RNA can be extracted from a cell etc. by lengthening stirring time.
- RNA adsorption / decomposition experiment Next, it was confirmed whether or not RNA was adsorbed on the nanowires 4 leaked into the suspension.
- FIG. 5 is a graph showing the relationship between the stirring time and the number of cycles in Example 3 and Comparative Examples 6 and 7.
- the number of cycles of mRNA increased, that is, the amount of RNA decreased as the stirring time increased. From this, it was found that mRNA was adsorbed to ZnO particles during the stirring step.
- the number of cycles hardly changed, that is, there was no increase or decrease in the amount of mRNA. From the above results, it was found that when the crushing liquid containing the nanowire 4 was used, RNA leaked into the suspension by the stirring process was not adsorbed to the nanowire 4 or decomposed.
- chloroform When biomolecules are extracted from cells or the like by a chemical disruption method, chloroform is generally added to disrupt cell walls and cell membranes, and to separate them from layers containing biological components after disruption. When the disruption liquid of the present invention was used, it was confirmed whether biomolecules could be disrupted and extracted from cells or the like without adding chloroform.
- Example 4 In the procedure of Example 2, except that 140 ⁇ L of chloroform was not added, the total RNA of the 0 minute and 120 minute samples was extracted in the same procedure as in Example 2, and the number of cycles was counted.
- FIG. 6 is a graph showing the relationship between the stirring time and the number of cycles in Example 4, Comparative Examples 8 and 9, and Comparative Example 4 in which cells were chemically disrupted.
- the number of cycles after stirring for 120 minutes was the chemical crushing of Comparative Example 4. The value was close to the number of cycles of the law.
- chloroform was required to damage the cell wall and cell membrane.
- chloroform is unnecessary for the subsequent analysis, it was separated from the aqueous phase fraction containing biomolecules. It was necessary to remove.
- the disruption liquid of the present invention when used, after disrupting cells and the like with the nanowire 4, the nanowire 4 can be removed by centrifugation, so that biomolecules can be efficiently extracted without performing phase separation. be able to. From the above results, it was revealed that the biomolecules can be extracted from the cells and the like without using any chloroform that may affect the biomolecules when the disrupted liquid of the present invention is used.
- Example 5 [DNA extraction and quantification experiments] ⁇ Example 5> [DNA extraction] In place of miRNeasy Mini of Qiagen in Example 2, Thermo GeneJET Genomic DNA Purification Kit was used, and instead of GAPDH mRNA, GAPDH expression level was used as an index, DNA was purified by the following procedure, and PCR was performed. The number of cycles was counted. First, 1 ⁇ 10 6 Hela cells were centrifuged (250 ⁇ g, 25 ° C., 5 minutes), the supernatant was discarded, and the pellets were washed once with PBS and processed in the same manner as in Example 1.
- the suspension was resuspended in 400 ⁇ L of the prepared disrupted solution, and vortexed (2,560 rpm using a VWR vortex geneny) for 0 minutes, 5 minutes, 10 minutes, 30 minutes, 60 minutes, and 120 minutes. Next, after stirring at 20 rpm and 56 ° C. (hybridization inc.) For 10 minutes, 20 ⁇ L of RNase A was added, allowed to stand at room temperature for 10 minutes, centrifuged at 250 ⁇ g, 25 ° C. for 5 minutes, and the supernatant was 400 ⁇ L. Was taken in a 1.5 mL tube, 50% ethanol (diluted by Wako) was added and vortexed.
- ⁇ Comparative Example 12> The number of cycles was counted in the same procedure as in Example 5 except that Hela cells were chemically disrupted using the GeneJET Genomic DNA Purification Kit manufactured by Thermo instead of the disruption solution prepared in Example 1.
- FIG. 7 is a graph showing the relationship between the stirring time of Example 5 and Comparative Examples 10 to 12 and the number of cycles.
- Example 5 using the crushing liquid in which nanowires 4 are dispersed the amount of DNA extracted increases with stirring time, and when stirred for 120 minutes, Comparative Example 10 using a chemical crushing liquid is used. More DNA could be extracted. From the above results, it became clear that DNA can be extracted from cells and the like without using a chemical disruption solution by using the disruption solution containing the nanowire 4 of the present invention.
- Example 6 [Preparation of crushing liquid containing nanowire 4 with Protease K immobilized]
- the crushing liquid containing nanowire 4 having an absorbance of 0.630 in Example 1 was mixed with Protease K solution (GeneJET Genomic DNA Purification Kit manufactured by Thermo) and allowed to stand for 10 minutes, and then 5424R manufactured by Eppendorf was used. The mixture was centrifuged at 1,000 rpm for 3 minutes, 400 ⁇ L of the supernatant was taken, and 400 ⁇ L of PBS buffer solution was added to prepare a crushed solution containing nanowires 4 to which Protease K was fixed.
- Protease K solution GeneJET Genomic DNA Purification Kit manufactured by Thermo
- Example 7 [Fracture experiment using nanowire 4 with immobilized Protease K] The suspension stirred for 120 minutes was sampled in the same procedure as in Example 2 except that the crushed liquid produced in Example 6 was used instead of the crushed liquid produced in Example 1. The sampled suspension was purified using a Thermo GeneJET Genomic DNA Purification Kit, and the DNA concentration was measured using a spectrophotometer (NanoDrop (registered trademark, manufactured by LMS Co., Ltd.)). It was measured.
- Example 1 The suspension stirred for 120 minutes in Example 2 was measured in the same manner as in Example 7.
- FIG. 8 is an absorbance chart showing the analysis results of Example 7 and Reference Example 1. This chart shows that 260/280, which is the ratio of absorbance at 260 nm, which is the peak of nucleic acid, and 280 nm, which is the peak of protein, is 1.8 to 2.0, and no protein is mixed (pure). . In addition, if 260/230, which is the ratio of 230 nm to 260 nm, which is the peak of impurities, is larger than 1.8, it indicates that there are few impurities (pure). As is clear from the chart shown in FIG.
- Example 8 On the quartz glass substrate 1 (Crystal Base Co.), the gold catalyst 3 was deposited to a thickness of 3 nm by sputtering. Next, a core nanowire was manufactured by performing pulse laser deposition for 10 minutes at room temperature with SnO 2 as a material. Next, a coating layer was formed around the core nanowire by sputtering with SiO 2 as a material at room temperature for 3 to 4 minutes. Next, the substrate 1 is immersed in 1 mL of ethanol and subjected to ultrasonic treatment at 25 ° C. using an ultrasonic device (US-1, manufactured by Asone) at 38 kHz (80 W) for about 2 hours. The nanowire 4 was peeled from the substrate 1.
- US-1 ultrasonic device
- the ethanol was collected by centrifugation, then washed twice with 500 ⁇ L of ethanol, and the ethanol was centrifuged at 21,130 g for 1 hour to precipitate the nanowires 4. After removing the supernatant, it was resuspended in ethanol and centrifuged at 21,130 g for 1 hour to precipitate the nanowires 4. The supernatant was removed and dried in a vacuum box.
- the nanowire 4 after drying is mixed with water so that the measured value of optical density (OD) at 405 nm is 0.1, and the nanowire 4 is suspended by sonication for 20 minutes, Produced.
- the diameter of the nanowire 4 contained in the produced crushed liquid was 30 nm, and the average length was 2 ⁇ m.
- Example 9 A crushed liquid was prepared in the same procedure as in Example 8 except that the sputtering for forming the coating layer was performed for 10 minutes.
- the nanowire 4 contained in the prepared crushed liquid had a diameter of 110 nm and an average length of 2 ⁇ m.
- Bacillus subtilis (ATCC6633 spore solution, Eiken Chemical Co., Ltd.) was introduced into 2 mL of LB medium and cultured at 37 ° C. and 125 rpm for 5 hours. 1 mL of the culture solution was sampled and centrifuged at 25 ° C. and 5,000 g for 10 minutes to sediment the bacteria, and the supernatant was removed. Next, the bacteria were resuspended with 1 mL of 10 mM phosphate buffer, centrifuged under the same conditions as described above, and washed again by reprecipitation of the bacteria. This washing operation was performed twice. The washed cells were suspended again in 10 mM phosphate buffer so that the OD (584 nm) was 0.4, and used as a sample.
- Example 10 5 ⁇ L each of the disrupted liquid prepared in Example 8 and the Bacillus subtilis suspension prepared in the above [Preparation of Sample] were mixed and stirred at 2,560 rpm for 1 hour using a VWR vortex geneny.
- FIG. 9 (1) is an SEM photograph at the end of stirring. After stirring, the residue was removed by centrifugation at 5,000 g for 10 minutes, and then the absorbance at 260 nm was measured using a spectrophotometer (NanoDrop (registered trademark, manufactured by LMS Co., Ltd.)). Quantification of DNA was performed.
- Example 11 The Bacillus subtilis was crushed by the same procedure as in Example 10 except that the crushing solution prepared in Example 9 was used, and DNA was quantified.
- FIG. 9 (2) is an SEM photograph at the end of stirring.
- FIG. 9 (3) is an SEM photograph at the end of stirring.
- FIG. 10 shows the DNA concentrations in the suspensions obtained in Examples 10 and 11 and Comparative Example 13. As is clear from FIG. 10, it was confirmed that the nanowire 4 having a smaller diameter is more likely to crush Bacillus subtilis, and as a result, more DNA can be extracted.
- the sample disruption method, biomolecule extraction method, and nanowire-containing disruption liquid of the present invention are used for sample preparation for more accurate analysis of biomolecules in medical institutions, universities, companies, research institutions, etc. Useful.
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
本発明は、サンプルの破砕方法、生体分子の抽出方法、及びナノワイヤを含む破砕液に関するものである。特に、細胞、ウイルス、菌等(以下「細胞等」と記載することもある。)のサンプルを、ナノワイヤを含む破砕液(以下、単に「破砕液」と記載することもある。)に懸濁して撹拌することで、溶解等の前処理をすることなく細胞等を破砕し、DNA(deoxyribonucleic acid)及びRNA(ribonucleic acid)(以下、DNA及びRNAを「核酸」と記載することもある。)、タンパク質等の生体分子を回収することができる、サンプルの破砕方法、生体分子の抽出方法、及びナノワイヤを含む破砕液に関するものである。 The present invention relates to a sample crushing method, a biomolecule extraction method, and a crushing liquid containing nanowires. In particular, a sample of cells, viruses, bacteria, etc. (hereinafter sometimes referred to as “cells”) is suspended in a disruption solution containing nanowires (hereinafter also simply referred to as “disruption solution”). By stirring the cells, the cells and the like are disrupted without pretreatment such as lysis, and DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) (hereinafter, DNA and RNA may also be referred to as “nucleic acid”). The present invention relates to a sample crushing method, a biomolecule extraction method, and a crushing liquid containing nanowires, which can recover biomolecules such as proteins.
近年、分子生物学の進歩により、病院等の医療機関の現場では、遺伝子欠失や薬剤感受性SNP(Single Nucleotide Polymorphism)などの遺伝子診断、病原菌等による感染症の診断やアレルゲンの診断等、遺伝子解析に基づく診断等が広がりつつあり、細胞等から遺伝子である核酸を効率的且つ簡便な操作で抽出する方法が求められている。また、遺伝子診断以外にも、例えば、細胞等からタンパク質を抽出し、抽出したタンパク質が癌マーカータンパク質であるか同定を行うことで癌診断が行われており、核酸と同様、細胞等から効率的かつ簡単な操作でタンパク質を抽出する方法が求められている。 In recent years, due to advances in molecular biology, genetic analysis such as gene diagnosis such as gene deletion and drug susceptibility SNP (Single Nucleotide Polymorphism), diagnosis of infectious diseases due to pathogenic bacteria, and allergen diagnosis in hospitals and other medical institutions Accordingly, there is a need for a method for extracting a nucleic acid, which is a gene, from a cell or the like by an efficient and simple operation. In addition to genetic diagnosis, for example, a cancer diagnosis is performed by extracting a protein from a cell and identifying whether the extracted protein is a cancer marker protein. There is also a need for a method for extracting proteins with simple operations.
細胞等から核酸やタンパク質等の生体分子を抽出する方法としては、試薬や酵素等を用いて細胞等を破砕して生体分子を抽出する方法が知られている。そして、そのためのキットも複数の会社から市販されており、比較的簡単に細胞等から生体分子を抽出することができる。 As a method of extracting biomolecules such as nucleic acids and proteins from cells and the like, a method of extracting biomolecules by crushing cells and the like using reagents and enzymes is known. Kits for this purpose are also commercially available from several companies, and biomolecules can be extracted from cells and the like relatively easily.
しかしながら、上記の細胞等を破砕して生体分子を抽出するキットには、フェノール、クロロホルム、界面活性剤等の試薬が含まれており、これらの試薬が、破砕・抽出後の生体分子を変性したり、分析に悪影響を及ぼす可能性があることが知られている(非特許文献1、2、3参照)。
However, the above-mentioned kit for crushing cells and the like to extract biomolecules contains reagents such as phenol, chloroform and surfactant, and these reagents denature the biomolecules after crushing and extraction. It is known that the analysis may be adversely affected (see
一方、試薬を用いない細胞等の破砕方法としては、基板上に設けたナノワイヤに細胞等を擦り付けるように移動させることで、細胞等を破砕する方法が知られている(非特許文献3参照)。しかしながら、非特許文献3に記載されている方法は、何れも基板に設けたマイクロ流路内にナノワイヤを成長させたものである。したがって、破砕処理できる細胞等の量は、マイクロ流路のサイズ及び単位時間当たりの流量の制限を受けるため、破砕効率が悪いという問題がある。
On the other hand, as a method for disrupting cells and the like without using a reagent, a method is known in which cells and the like are disrupted by moving the cells or the like so as to rub against a nanowire provided on a substrate (see Non-Patent Document 3). . However, all of the methods described in
また、非特許文献3に記載された発明は、マイクロ流路内で成長したナノワイヤ束間に細胞等を所定以上の流速で流して通過する際に細胞等を破砕する発明であるが、ナノワイヤ束間の間隔が一定である。そのため、例えば、ナノワイヤ束間の間隔を狭くすると、破砕する細胞等が大きな場合は目詰まりが起こり易くなり、逆に、ナノワイヤ束間の間隔を広くすると、破砕する細胞等が小さな場合はナノワイヤ束間を通過し、破砕し難くなる。その為、破砕する細胞等の大きさに応じて、ナノワイヤ束間の間隔が異なるチップを準備する必要があり、非効率であるという問題がある。更に、非特許文献3に記載されている発明は、マイクロ流路内にナノワイヤを成長させることから、成長後のナノワイヤの表面を、細胞等の破砕後に目的とする生体成分を抽出するための処理を施すことは難しいという問題がある。
In addition, the invention described in Non-Patent
本発明は、上記従来の問題を解決するためになされた発明であり、鋭意研究を行ったところ、ナノワイヤを含む破砕液に細胞等のサンプルを懸濁し、次いで、サンプルを懸濁した破砕液を撹拌することで、試薬等を使用することなく、細胞等を効率よく破砕できることを新たに見出した。更に、タンパク質分解酵素、リボヌクレアーゼ、及びデオキシリボヌクレアーゼから選択される1種又は2種を固定したナノワイヤを用いることで、DNA、RNA、及びタンパク質等の生体分子を高純度で抽出できることを新たに見出し、本発明を完成した。 The present invention is an invention made to solve the above-mentioned conventional problems, and as a result of extensive research, a sample such as a cell is suspended in a disruption solution containing nanowires, and then a disruption solution in which the sample is suspended is obtained. It was newly found that, by stirring, cells and the like can be efficiently disrupted without using a reagent or the like. Furthermore, it has been newly found that biomolecules such as DNA, RNA, and protein can be extracted with high purity by using nanowires in which one or two selected from proteolytic enzymes, ribonucleases, and deoxyribonucleases are immobilized. The present invention has been completed.
すなわち、本発明の目的は、ナノワイヤを用いたサンプルの破砕方法、生体分子の抽出方法、及びナノワイヤを含む破砕液を提供することである。 That is, the object of the present invention is to provide a method for crushing a sample using nanowires, a method for extracting biomolecules, and a crushing liquid containing nanowires.
本発明は、以下に示す、ナノワイヤを用いたサンプルの破砕方法、生体分子の抽出方法、及びナノワイヤを含む破砕液に関する。 The present invention relates to a sample disruption method using nanowires, a biomolecule extraction method, and a disruption solution containing nanowires, as described below.
(1)ナノワイヤを含む破砕液に細胞、ウイルス、及び菌から選択されるサンプルを懸濁する懸濁工程、
サンプルを懸濁した破砕液を撹拌する撹拌工程、
を含む、サンプルの破砕方法。
(2)ナノワイヤを含む破砕液に細胞、ウイルス、及び菌から選択されるサンプルを懸濁する懸濁工程、
サンプルを懸濁した破砕液を撹拌する撹拌工程、
撹拌した破砕液を遠心分離して残渣を取り除く残渣除去工程、
を含む、生体分子の抽出方法。
(3)ナノワイヤが、タンパク質分解酵素、リボヌクレアーゼ、及びデオキシリボヌクレアーゼから選択される1種又は2種が固定されたナノワイヤである、上記(2)に記載の生体分子の抽出方法。
(4)ナノワイヤを含む、細胞、ウイルス、及び菌から選択されるサンプルの破砕液。
(5)ナノワイヤが、タンパク質分解酵素、リボヌクレアーゼ、及びデオキシリボヌクレアーゼから選択される1種又は2種が固定されたナノワイヤである、上記(4)に記載のサンプルの破砕液。
(1) A suspension step of suspending a sample selected from cells, viruses, and fungi in a disruption solution containing nanowires,
A stirring step of stirring the crushed liquid in which the sample is suspended;
A method for crushing a sample.
(2) A suspension step of suspending a sample selected from cells, viruses, and fungi in a disruption solution containing nanowires,
A stirring step of stirring the crushed liquid in which the sample is suspended;
A residue removal step of removing the residue by centrifuging the stirred crushed liquid,
A method for extracting biomolecules.
(3) The method for extracting a biomolecule according to (2) above, wherein the nanowire is a nanowire on which one or two selected from proteolytic enzymes, ribonucleases, and deoxyribonucleases are immobilized.
(4) A sample disruption solution selected from cells, viruses, and fungi containing nanowires.
(5) The sample disruption liquid according to (4) above, wherein the nanowire is a nanowire on which one or two selected from proteolytic enzymes, ribonucleases, and deoxyribonucleases are immobilized.
本発明は、ナノワイヤを含む破砕液でサンプルを破砕することができるので、サンプルの破砕の際に試薬等を用いる必要が無い。したがって、サンプルの破砕後に破砕液中に漏出する核酸やタンパク質等の生体分子が変性することがなく、また、抽出した生体分子の分析に悪影響を及ぼす恐れが無い、又は低減できる。 In the present invention, since the sample can be crushed with the crushing liquid containing nanowires, it is not necessary to use a reagent or the like when crushing the sample. Therefore, biomolecules such as nucleic acids and proteins that leak into the crushing liquid after crushing the sample are not denatured, and there is no possibility that the analysis of the extracted biomolecules may be adversely affected or can be reduced.
本発明は、ナノワイヤを含む破砕液にサンプルを懸濁して撹拌することでサンプルを破砕する。したがって、従来技術のようにマイクロ流路の容量及び流速の制限を受けることがなく、また、破砕液に含まれるすべてのナノワイヤがサンプルの破砕に寄与するので、一度に大量のサンプルを短時間で破砕処理することができる。 In the present invention, the sample is crushed by suspending and stirring the sample in a crushing liquid containing nanowires. Therefore, there is no limitation on the capacity and flow rate of the micro-channel as in the prior art, and all the nanowires contained in the disruption liquid contribute to the disruption of the sample. It can be crushed.
本発明は、破砕液中でナノワイヤは分散した状態で撹拌されることから、破砕後のサンプルの残渣による目詰まりの恐れがない、又は低減できる。 In the present invention, since the nanowires are stirred in the crushing liquid in a dispersed state, there is no risk of clogging due to the residue of the sample after crushing or it can be reduced.
本発明の破砕液には、タンパク質分解酵素、リボヌクレアーゼ、及びデオキシリボヌクレアーゼから選択される1種又は2種が固定されたナノワイヤを分散することができる。したがって、目的とする生体分子を高純度で回収することができる。 In the crushing liquid of the present invention, nanowires on which one or two selected from proteolytic enzymes, ribonucleases, and deoxyribonucleases are immobilized can be dispersed. Therefore, the target biomolecule can be recovered with high purity.
以下に、ナノワイヤを用いたサンプルの破砕方法、生体分子の抽出方法、及びナノワイヤを含む破砕液について詳しく説明する。 Hereinafter, a sample crushing method using nanowires, a biomolecule extraction method, and a crushing solution containing nanowires will be described in detail.
本発明のナノワイヤを含む破砕液は、ナノワイヤを分散液に分散することで作製することができる。なお、本発明における「ナノワイヤ」とは、分散液に分散して細胞等と撹拌した際に細胞等に損傷を与えて破砕できるものであれば、製造方法、サイズ、材質等に特に制限は無い。 The crushing liquid containing the nanowire of the present invention can be prepared by dispersing the nanowire in a dispersion liquid. The “nanowire” in the present invention is not particularly limited in terms of production method, size, material, etc., as long as it can be crushed by damaging cells and the like when dispersed in a dispersion and stirred with cells and the like. .
図1は、本発明の破砕液に用いるナノワイヤの作製手順の一例を示す図であり、次の手順でナノワイヤを作製することができる。
(1)基板1を準備する。
(2)基板1上にナノワイヤ作製用の粒子2又は触媒3を塗布する。
(3)基板1上にナノワイヤ4を成長させる。
(4)流水処理、または超音波処理することで、ナノワイヤ4を基板1から剥離する。
(5)剥離したナノワイヤ4を洗浄し、遠心分離を行う。
(6)分離したナノワイヤ4をエッペンドルフチューブ等の容器5に入れ分散液6に分散して破砕液を作製する。
FIG. 1 is a diagram showing an example of a procedure for producing nanowires used in the crushed liquid of the present invention. Nanowires can be produced by the following procedure.
(1) The
(2) The nanowire-producing
(3) The
(4) The
(5) The separated
(6) The separated
前記基板1の材料は、PDMS(poly(dimethylsiloxane))、PMMA(poly(methyl methacrylate))、PC(polycarbonate)、硬質ポリエチレン製等のプラスチック、シリコン、ガラス等、ナノワイヤ4が成長できるものであれば特に制限はない。
The material of the
ナノワイヤ4作製用の粒子2としては、例えば、ZnOが挙げられる。ZnO微粒子を用いたナノワイヤ4は、前記非特許文献3に記載されている水熱合成方法を用いて作製することができる。具体的には、先ず、ZnO粒子を基板1上に塗布する。次いで、硝酸亜鉛六水和物(Zn(NO3)2・6H2O)、ヘキサメチレンテトラミン(C6H12N4)を脱イオン水に溶解した前駆体溶液に、加熱した基板1を浸漬させることで、ZnOナノワイヤ4を成長させることができる。
Examples of the
ナノワイヤ4作製用の触媒3としては、例えば、金、プラチナ、アルミニウム、銅、鉄、コバルト、銀、錫、インジウム、亜鉛、ガリウム等が挙げられる。触媒3を用いたナノワイヤ4は、次の手順で作製することができる。
(a)触媒3を基板1上に堆積する。
(b)SiO2、Li2O、MgO、Al2O3、CaO、TiO2、Mn2O3、Fe2O3、CoO、NiO、CuO、ZnO、Ga2O3、SrO、In2O3、SnO2、Sm2O3、EuO等の材料を用い、パルスレーザーデポジション、VLS(Vapor-Liquid-Solid)法等の物理蒸着法でコアナノワイヤを形成する。
(c)破砕・抽出した核酸が静電的相互作用により吸着し難い材料であるSiO2、TiO2等を用い、スパッタリング、EB(Electron Beam)蒸着、PVD(Physical Vapor Deposition)、ALD(Atomic Layer Deposition)等の一般的な蒸着法により、コアナノワイヤの周囲に被覆層を形成する。
なお、触媒3を用いて作製するナノワイヤ4は、分岐鎖を有しないナノワイヤ4であってもよいし、分岐鎖を有するナノワイヤ4であってもよい。
Examples of the
(A) The
(B) SiO 2, Li 2 O, MgO, Al 2
(C) SiO 2 , TiO 2, etc., which are materials that are difficult to adsorb crushed / extracted nucleic acid due to electrostatic interaction, sputtering, EB (Electron Beam) deposition, PVD (Physical Vapor Deposition), ALD (Atomic Layer) A coating layer is formed around the core nanowire by a general vapor deposition method such as Deposition).
In addition, the
ナノワイヤ4の直径は、上記のとおり、撹拌することで細胞等に損傷を与えて破砕できるサイズであれば特に制限は無いが、破砕する目的である細胞、ウイルス、菌等の大きさ、細胞膜又は細胞壁の強度等に応じて変えてもよい。例えば、原核細胞は1μm~10μm、真核細胞は5μm~10μm、ウイルスは数10nm~数100nm、血球細胞は7μm~15μmの大きさであることから、ナノワイヤ4の直径は、10nm以上、15nm以上、20nm以上、又は25nm以上であってもよい。また、ナノワイヤ4の直径は、破砕する目的である細胞等よりは小さい必要があり、例えば、200nm以下、150nm以下、100nm以下、90nm以下、80nm以下、70nm以下、60nm以下、又は50nm以下であってもよい。
The diameter of the
ナノワイヤ4の直径は、粒子2を用いて形成する場合は、粒子2のサイズを変更する、または、作製したナノワイヤ4に被覆層を形成することで適宜調整することができる。被覆層は、触媒3を用いた場合の被覆層と同じ材料及び被覆方法で形成されてもよく、蒸着時間を適宜調整すればよい。また、触媒3を用いて成長させる場合も、被覆層を形成する際の蒸着時間を変えることで直径を適宜調整することができる。
The diameter of the
本発明においては、遊離しているナノワイヤ4と細胞等を撹拌し、ナノワイヤ4が細胞等に当接した際に、アスペクト比の違いによる長さ方向への慣性力によりナノワイヤ4が細胞等を破損すると考えられる。ナノワイヤ4の長さは、撹拌することで細胞等に損傷を与えて破砕できる長さであれば特に制限は無いが、300nm以上が好ましい。300nmより小さいと粒子2とほぼ変わらず、細胞等に当接しても長さが短いので損傷を与え難くなり好ましくない。一方、ナノワイヤ4の長さは、破砕したい細胞等のサイズより長くなると接触の確率が減少し、また、ナノワイヤ4同士が絡まり易くなるので、4μm程度までにした方が好ましい。ナノワイヤ4の長さは、粒子2を用いて形成する場合は、前駆体溶液への浸漬時間を変えることで調整することができる。また、ナノワイヤ4の長さは、触媒3を用いて形成する場合は、コアナノワイヤを形成した後のVLSによる成長時間を変えることで適宜調整することができる。
In the present invention, when the
基板1上に成長したナノワイヤ4は、流水処理で基板1から剥離することができるが、必要に応じて、分散液6に基板1を浸漬させ超音波処理することで基板1からナノワイヤ4を剥離してもよい。超音波処理は、市販されている一般的な超音波処理装置を用いて数分程度、行えばよい。
The
本発明の破砕液は、基板1から剥離したナノワイヤ4を分散液6に加え、超音波処理により凝集したナノワイヤ4を分散させることで作製できる。破砕液中のナノワイヤ4の濃度は、細胞等の濃度に応じて適宜調整すればよく、濃度は分光光度計の吸光度が所望の数値となるように調整すればよい。
The crushing liquid of the present invention can be produced by adding
ナノワイヤ4の分散液6は、核酸、タンパク質等の生体分子を変性したり、その後の分析に影響を与えない液体であれば特に問題はなく、例えば、リン酸緩衝生理食塩水(PBS)等の緩衝液が挙げられる。
The
なお、本発明においては、回収したナノワイヤ4を、そのまま分散液6に分散してもよいが、ナノワイヤ4を処理してから分散液6に分散してもよい。例えば、本発明の破砕液を用いて核酸を回収する場合は、回収したナノワイヤ4の周りに、Protease K、エンドペプチダーゼ、エキソペプチダーゼ等のタンパク質分解酵素を固定することで、破砕液と細胞等の撹拌中に破砕液中に漏出するタンパク質を分解できるようにしてもよい。タンパク質分解酵素は、タンパク質分解酵素を含む溶液中に回収したナノワイヤ4を懸濁して所定時間放置した後、蒸留水等で洗浄することでナノワイヤ4に固定することができる。
In the present invention, the collected
また、本発明の破砕液を用いてタンパク質を回収する場合は、回収したナノワイヤ4の周りに、核酸分解酵素(RNAを分解するRNaseA、RNaseL等のリボヌクレアーゼ、DNAを分解するDNaseI、DNaseII等のデオキシリボヌクレアーゼ)を固定することで、破砕液と細胞等の撹拌中に破砕液中に漏出する核酸を分解できるようにしてもよい。核酸分解酵素は、核酸分解酵素を含む溶液中に回収したナノワイヤ4を懸濁して所定時間放置した後、蒸留水等で洗浄することでナノワイヤ4に固定することができる。
In addition, when proteins are recovered using the disrupted liquid of the present invention, nucleic acid-degrading enzymes (RNase A, RNase L, etc., which degrade RNA, deoxygenases, such as DNase I, DNase II, etc., which degrade DNA, are collected around the collected
更に、本発明においては、上記のタンパク質分解酵素及び核酸分解酵素を組合せて用いてもよい。例えば、本発明の破砕液を用いてDNAを高純度で抽出する場合は、ナノワイヤ4に、タンパク質分解酵素及びリボヌクレアーゼを固定し、RNAを高純度で抽出する場合は、ナノワイヤ4にタンパク質分解酵素及びデオキシリボヌクレアーゼを固定すればよい。タンパク質分解酵素及び核酸分解酵素は、タンパク質分解酵素及びリボヌクレアーゼの混合溶液、又はタンパク質分解酵素及びデオキシリボヌクレアーゼの混合溶液に回収したナノワイヤ4を懸濁して所定時間放置した後、蒸留水等で洗浄することでナノワイヤ4に固定することができる。
Furthermore, in the present invention, the above proteolytic enzyme and nucleolytic enzyme may be used in combination. For example, when DNA is extracted with high purity using the disruption solution of the present invention, a proteolytic enzyme and ribonuclease are immobilized on the
次に、本発明の破砕液を用いたサンプルの破砕方法、生体分子の抽出方法について説明する。なお、本発明において「サンプル」とは、破砕液を用いて破砕することで内部の生体分子を回収できるものを意味し、上記のとおり、細胞、ウイルス、菌等が挙げられる。より具体的には、細胞としては細胞膜構造を有するものが挙げられ、ブドウ球菌、枯草菌、大腸菌、サルモネラ菌、緑膿菌、コレラ菌、赤痢菌、炭疽菌、結核菌、ボツリヌス菌、破傷風菌、レンサ球菌等の細菌類、顆粒球、リンパ球、網赤血球、赤血球、白血球、血小板等の血球細胞、等が挙げられる。ウイルスとしては、ノロウイルス、ロタウイルス、インフルエンザウイルス、アデノウイルス、コロナウイルス、麻疹ウイルス、風疹ウイルス、肝炎ウイルス、ヘルペスウイルス、HIV等が挙げられる。菌としてはキノコ、カビ、酵母などが挙げられ、具体的には、白癬菌、カンジダ、アスペルギルス、出芽酵母等が挙げられる。また、ミトコンドリア、エクソソームや細胞外小嚢もサンプルとして挙げられる。なお、サンプルとしては、破砕によりその内部の物質を回収できるものであれば、上記例に限られない。 Next, a sample crushing method and a biomolecule extraction method using the crushing liquid of the present invention will be described. In the present invention, the “sample” means one that can recover internal biomolecules by crushing using a crushing solution, and examples thereof include cells, viruses, and fungi. More specifically, the cells include those having a cell membrane structure, such as staphylococci, Bacillus subtilis, Escherichia coli, Salmonella, Pseudomonas aeruginosa, Vibrio cholerae, Shigella, Bacillus anthracis, tuberculosis, Clostridium botulinum, tetanus, Examples include bacteria such as streptococci, granulocytes, lymphocytes, reticulocytes, erythrocytes, leukocytes, blood cells such as platelets, and the like. Examples of viruses include norovirus, rotavirus, influenza virus, adenovirus, coronavirus, measles virus, rubella virus, hepatitis virus, herpes virus, HIV and the like. Examples of the fungi include mushrooms, molds, and yeasts, and specifically include ringworm fungi, Candida, Aspergillus, and budding yeast. Mitochondria, exosomes and extracellular vesicles can also be mentioned as samples. Note that the sample is not limited to the above example as long as the material inside the sample can be recovered by crushing.
細胞等のサンプルの破砕は、以下に記載する手順で行うことができる。先ず、遠心分離等により回収した細胞等を破砕液に懸濁して懸濁液を作製する工程を行う。懸濁液は、エッペンドルフチューブ等の生体分子に影響を与えにくい公知の容器5に入れて作製すればよい。なお、懸濁液中のナノワイヤ4の濃度及び細胞等の濃度は、撹拌工程で両者が懸濁液中で十分に撹拌され、ナノワイヤ4の先端が細胞等に接触することで細胞等が損傷・破砕する濃度であれば特に制限はない。
The crushing of a sample such as a cell can be performed according to the procedure described below. First, a step of suspending cells collected by centrifugation or the like in a disruption solution to prepare a suspension is performed. The suspension may be prepared by putting it in a known
懸濁液を作製する工程の後に、懸濁液を撹拌する工程を行う。撹拌工程は、ナノワイヤ4と細胞等を撹拌することができれば特に制限は無い。例えば、ボルテックスミキサーを用いて容器5を撹拌してもよいし、或いは、マグネチックスターラーの撹拌子を容器5内に入れ撹拌してもよい。撹拌速度及び時間は、ナノワイヤ4の濃度、サンプルの種類及び濃度に応じて適宜調整すればよい。
After the step of preparing the suspension, a step of stirring the suspension is performed. The stirring step is not particularly limited as long as the
上記の工程により、細胞等の前処理を行うことなく、また、生体分子に変性等の影響を与える試薬を使用することなく、細胞等を破砕して生体分子を漏出することができる。 Through the above-described steps, it is possible to break up cells and leak biomolecules without pretreatment of cells and the like and without using reagents that affect biomolecules such as denaturation.
撹拌工程の後に、遠心分離等による懸濁液の残渣除去工程を実施することで、懸濁液中のナノワイヤ4、未破砕の細胞等及び細胞壁等の残渣を沈殿・除去し、生体分子を抽出することができる。
After the agitation step, the suspension residue removal step such as centrifugation is performed to precipitate and remove residues such as
また、上記のとおり、タンパク質分解酵素、リボヌクレアーゼ、及びデオキシリボヌクレアーゼから選択される1種又は2種が固定されたナノワイヤ4を用いた場合、撹拌工程中に懸濁液中に漏出した生体分子がナノワイヤ4に固定した酵素により分解されるので、所望の生体分子を高純度で抽出することができる。更に、ナノワイヤ4に酵素を固定化した場合、撹拌工程後にナノワイヤ4を遠心分離等で取り出すことで酵素も同時に懸濁液中から取り出すことができるので、懸濁液中に生体分子を分解する酵素を加える場合と比較して、生体分子を分解する酵素を簡単に除去することができる。
In addition, as described above, when the
勿論、ナノワイヤ4に、タンパク質分解酵素、リボヌクレアーゼ、又はデオキシリボヌクレアーゼから選択される1種又は2種の酵素を固定することに代え、撹拌工程時、又は撹拌工程後に前記酵素を添加してもよい。その場合、酵素により生体分子を分解した後に、定法にしたがって添加した酵素を懸濁液から除去すればよい。
Of course, instead of immobilizing one or two kinds of enzymes selected from proteolytic enzymes, ribonucleases, or deoxyribonucleases to the
以下に実施例を掲げ、本発明を具体的に説明するが、この実施例は単に本発明の説明のため、その具体的な態様の参考のために提供されているものである。これらの例示は本発明の特定の具体的な態様を説明するためのものであるが、本願で開示する発明の範囲を限定したり、あるいは制限することを表すものではない。 Hereinafter, the present invention will be specifically described with reference to examples. However, these examples are provided merely for the purpose of explaining the present invention and for reference to specific embodiments thereof. These exemplifications are for explaining specific specific embodiments of the present invention, but are not intended to limit or limit the scope of the invention disclosed in the present application.
〔破砕液の作製〕
<実施例1>
ZnO粒子としてNANOBYK(登録商標)-3820(ビックケミー・ジャパン社製;ZnOの直径:20nm)を5mLにクロスリンカーとして10-CDPA(同仁化学)を1.35mg(1mmol/L)混合した混合液を、室温で3日静置した。その後、混合液を10000倍希釈し、基板1(PMMA(poly(methyl methacrylate)、50mm×50mm)上に、ピペットを用いて、均一に塗布し、85℃で1時間定着させた。次に、硝酸亜鉛六水和物((Zn(NO3)2・6H2O、98%、シグマ・アドリッチ社製)を0.5608g、ヘキサメチレンテトラミン((C6H12N4)、99+%、シグマ・アドリッチ社製)を1.16g、脱イオン水200mLに加えて前駆体溶液を作成した。次に、基板1を前駆体溶液に入れ、85℃のオーブンに24時間浸漬させた。図2は、基板1上に成長したナノワイヤ4の電界放射型走査電子顕微鏡(Field Emission Scanning Electron Microscope;FESEM)写真である。次に、基板1をリン酸緩衝生理食塩水(PBS;5mL)で流水処理し、その後、当該PBS中に基板1を浸漬し、超音波装置(US-1、Asone社製)を用いて、38kHz(80W)で約1分半、超音波処理を行った。そのPBS5mLを、15mLの遠沈管(Iwaki社製)に入れ、超音波装置(UT-250S、Sharp社製)を用いて35kHz(200W)で約2時間、超音波処理を行い、ナノワイヤ4をPBSに高分散させた。次に、エッペンドルフ社製の5424Rにナノワイヤ4が分散した破砕液を入れ、遠心分離及び/又はPBSの添加により、BMG Labtech社製POLARstar OPTIMAを用いた際の破砕液の吸光度(405nmで測定)が0.630となるように破砕液中のナノワイヤ4の濃度を調整した。なお、破砕液中のナノワイヤ4の濃度を吸光度により定義しているのは、微小量のナノワイヤ4の重量を正確に測定することは困難であるが、図3に示すように、PBS溶液中のナノワイヤ4の濃度と吸光度は相関関係があるためである。作製したナノワイヤ4の直径は約100nm、平均長さは2μmであった。次に、1.5mLのエッペンドルフチューブに、700μLの破砕液を採取して実施例1の破砕液を作製した。
[Preparation of crushing liquid]
<Example 1>
A mixed solution in which NANOBYK (registered trademark) -3820 (produced by Big Chemie Japan Co., Ltd .; ZnO diameter: 20 nm) as ZnO particles was mixed with 5 mL and 1.35 mg (1 mmol / L) of 10-CDPA (Dojindo) as a crosslinker was mixed. And left at room temperature for 3 days. Thereafter, the mixed solution was diluted 10,000 times, and uniformly applied onto the substrate 1 (PMMA (poly (methymethacrylate), 50 mm × 50 mm) using a pipette, and fixed at 85 ° C. for 1 hour. 0.5608 g of zinc nitrate hexahydrate ((Zn (NO 3 ) 2 .6H 2 O, 98%, manufactured by Sigma Adrich), hexamethylenetetramine ((C 6 H 12 N 4 ), 99 + %, A precursor solution was prepared by adding 1.16 g of Sigma Adrich Co.) to 200 mL of deionized water, and then the
<比較例1>
実施例1のナノワイヤ4に代え、ZnO粒子(ビックケミー・ジャパン社製;ZnOの直径:20nm)を用い、吸光度を実施例1と同様に0.629にした以外は、実施例1と同様に破砕液を作製した。
<Comparative Example 1>
In place of the
<比較例2>
実施例1のナノワイヤ4を添加せず、PBS緩衝液のみをエッペンドルフチューブに入れたものを比較例2の破砕液として作製した。
<Comparative example 2>
The
〔RNAの抽出・定量実験〕
次に、実施例1、比較例1及び2の破砕液を用いて、Hela細胞からのRNAの抽出・定量実験を行った。
〔細胞、培地の調整〕
Hela細胞はECACC社より購入したものを用いた。Fetal Bovine Serum(FBS、Invitrogen)を55℃にて温浴し、30分間十分に失活させ、Minimum Essential Medium Eagle(シグマ・アルドリッチ社)にFBSの容量が10%となるように加え、さらにPenicillin-Streptomycin (SIGMA社製)が1%とL-GLUTAMINE(SIGMA社製)が1%、100X Non-Essential Amino Acids for MEM Eagle(MP Biomedicals社製)が1%となるように加えたものをHela細胞用培地とした。
[RNA extraction / quantification experiment]
Next, using the disrupted liquids of Example 1 and Comparative Examples 1 and 2, RNA extraction and quantification experiments were performed from Hela cells.
[Preparation of cells and medium]
Hela cells purchased from ECACC were used. Fetal Bovine Serum (FBS, Invitrogen) is warmed at 55 ° C., inactivated sufficiently for 30 minutes, added to Minimum Essential Medium Eagle (Sigma-Aldrich) so that the FBS capacity becomes 10%, and Penicillin− Streptomycin (manufactured by SIGMA) is 1%, L-GLUTAMINE (manufactured by SIGMA) is 1%, and 100X Non-Essential Amino Acids for MEM Eagle (manufactured by MP Biomedicals) is 1%. A culture medium was prepared.
〔培養方法〕
培養フラスコ(Iwaki社製)に前記培地と細胞を入れてコンフルエントになるまで培養した。次に、あらかじめ、培地、PBS(GIBCO、Life Technologies社製)、トリプシン/EDTA(GIBCO、Life Technologies社製)を37℃に温めておいた。細胞の状態を顕鏡し確認の後、アスピレーターとパスツールピペットを用い、培養容器内の培地を吸引廃棄した。培養に使用した量の約半量のPBSで1回洗浄後、25cm2あたり2mLのトリプシンを培養容器内に添加し、培養容器を37℃のCO2インキュベータ内に2分間静置した。細胞の状態を目視にて剥離しているかを確認し、必要に応じて、培養容器内の側面をそっとたたき、張り付いていた細胞を剥離させた。培養容器内に新しい培地を25cm2あたり3mL加え、トリプシンを不活性化させ再懸濁させた。懸濁液を15mLの遠沈管へ移し替えて1,000rpm、25℃、3分間遠心分離を行った。遠心分離後、上清をパスツールピペットで吸引廃棄した。残ったペレット状の細胞に新しい培地を加え、軽くピペッティングにて懸濁させた。この細胞懸濁液を調整し実験に用いた。
[Culture method]
The medium and cells were placed in a culture flask (Iwaki) and cultured until confluent. Next, the medium, PBS (GIBCO, manufactured by Life Technologies), and trypsin / EDTA (GIBCO, manufactured by Life Technologies) were warmed to 37 ° C. in advance. After confirming the state of the cells with a microscope, the medium in the culture vessel was aspirated and discarded using an aspirator and Pasteur pipette. After washing once with about half the amount of PBS used for the culture, 2 mL of trypsin per 25 cm 2 was added to the culture container, and the culture container was allowed to stand in a CO 2 incubator at 37 ° C. for 2 minutes. It was confirmed whether or not the state of the cells was peeled off visually, and if necessary, the side in the culture vessel was gently tapped to peel off the stuck cells. Fresh medium 3mL added per 25 cm 2 in a culture vessel, and resuspended to inactivate the trypsin. The suspension was transferred to a 15 mL centrifuge tube and centrifuged at 1,000 rpm at 25 ° C. for 3 minutes. After centrifugation, the supernatant was aspirated and discarded with a Pasteur pipette. A fresh medium was added to the remaining pellet-like cells and lightly suspended by pipetting. This cell suspension was prepared and used for experiments.
〔サンプルの調整〕
細胞懸濁液10μLをC-Chip(Digital Bio社製)へ注入し、顕微鏡を用い細胞数をカウントした。それぞれ目的の細胞数になるよう新しい培地を用いて希釈を行うことでサンプルの調整を行った。
[Sample adjustment]
10 μL of the cell suspension was injected into C-Chip (Digital Bio) and the number of cells was counted using a microscope. Samples were prepared by diluting with a new medium so as to obtain the desired number of cells.
<実施例2>
〔RNAの抽出〕
上記〔サンプルの調整〕により得られた約8.0×105個のHela細胞を、上記実施例1で作製した破砕液700μLに懸濁し、VWR社製のボルテックスジェニーを用い、2,560rpmで撹拌した。0分、5分、10分、30分、60分、120分間撹拌した懸濁液を全量、mRNAを定量するためにサンプリングした。サンプリングした各懸濁液に対して、Qiagen社のmiRNeasy Miniを用い、添付マニュアルにしたがってRNAの抽出・精製を行った。先ず、各懸濁液に140μLのクロロホルム(インフィニティピュア、Wako社製)を添加し、15秒手で攪拌後、室温で3分放置した。エッペンドルフ社製の5424Rを用いて4℃、13,000rpmで15分、遠心処理を行った後、上層の350μLを1.5mLチューブへ移した。525μLのエタノール(99.5%、インフィニティピュア、Wako社製)を加え、数回ピペッティングを行った。次に、700μLをスピンカラムへ移し、25℃、10,300rpm、15秒、遠心分離を行った。ろ液を廃棄し、RWT 700μLをスピンカラムへ移し、室温、10,300rpm、15秒、遠心分離を行い、同様にろ液を廃棄した。次に、500μLのRPEを入れ、室温、10,300rpm、15秒、遠心分離を行い、ろ液を廃棄した。再度RPEを入れ、室温、10,300rpm、1分、遠心分離を行った。スピンカラムを新規コレクションチューブへ移し替え、13,000rpm、1分、遠心分離を行った。再度、スピンカラムを新規1.5mLチューブへ移し、50μLのRNase free水を入れ、10,300rpm、1分、遠心分離を行った。上記手順により、50μLの全RNAを抽出した。
<Example 2>
[Extraction of RNA]
About 8.0 × 10 5 Hela cells obtained in the above [Preparation of sample] are suspended in 700 μL of the disrupted solution prepared in Example 1 above, using a VWR vortex jenny at 2,560 rpm. Stir. The suspensions stirred for 0 minutes, 5 minutes, 10 minutes, 30 minutes, 60 minutes, and 120 minutes were sampled in order to quantify the total amount of mRNA. For each sampled suspension, RNA extraction / purification was performed using miRNeasy Mini from Qiagen according to the attached manual. First, 140 μL of chloroform (Infinity Pure, manufactured by Wako) was added to each suspension, stirred for 15 seconds, and allowed to stand at room temperature for 3 minutes. Centrifugation was performed for 15 minutes at 4 ° C. and 13,000 rpm using 5424R manufactured by Eppendorf, and then 350 μL of the upper layer was transferred to a 1.5 mL tube. 525 μL of ethanol (99.5%, Infinity Pure, manufactured by Wako) was added, and pipetting was performed several times. Next, 700 μL was transferred to a spin column, and centrifuged at 25 ° C., 10,300 rpm, 15 seconds. The filtrate was discarded, 700 μL of RWT was transferred to a spin column, centrifuged at room temperature, 10,300 rpm, 15 seconds, and the filtrate was similarly discarded. Next, 500 μL of RPE was added, centrifuged at room temperature, 10,300 rpm, 15 seconds, and the filtrate was discarded. RPE was added again, and centrifugation was performed at room temperature, 10,300 rpm, and 1 minute. The spin column was transferred to a new collection tube and centrifuged at 13,000 rpm for 1 minute. The spin column was again transferred to a new 1.5 mL tube, 50 μL of RNase free water was added, and centrifugation was performed at 10,300 rpm for 1 minute. 50 μL of total RNA was extracted by the above procedure.
〔RNAの定量〕
抽出した各RNAに対して、ロシュ・アプライド・サイエンス社製のTranscriptor High Fidelity cDNA Synthesis Kitを用いて、RT-PCRを行った。RNA2μLに、アンカーオリゴプライマーを1μL、PCRグレード水を8.4μL加え、65℃で10分静置した後、4℃で保存した。そのサンプルにTranscriptor High Fidelity Reverse Transcriptase Reaction Buffer 5Xを4μL、Protector RNase Inhibitorを0.5μL、デオキシヌクレオチドMixを2μL、DTTを1μL、Transcriptor High Fidelity Reverse Transcriptaseを1.1μL加え、55℃で30分、85℃で5分、処理することでcDNAを作成し、4℃で保存した。qPCRはロシュ・アプライド・サイエンス社製のLight Cycler Fast Start DNA Master SYBR Green Iを使用した。キットの使用説明書に従い、PCRのサイクルは95℃で10分加熱した後、95℃で10秒、55℃で10秒、72℃で10秒の3つの工程を40-45サイクル行い、95℃で0秒、55℃で15秒処理し、60℃から95℃までメルティングカーブを描いた後に、40℃で30秒保温し、RNAの定量を行った。RNAの定量は、GAPDHのmRNAの発現レベルを指標とし、蛍光強度が7000に達するまでのPCRのサイクル数をカウントすることで行った。サイクル数が少ない程、RT-PCR開始時のRNAの量が多い、つまり、Hela細胞からより多くのRNAを抽出したことを意味する。
[Quantification of RNA]
RT-PCR was performed on each extracted RNA using a Transscriptor High Fidelity cDNA Synthesis Kit manufactured by Roche Applied Science. To 2 μL of RNA, 1 μL of anchor oligo primer and 8.4 μL of PCR grade water were added, left at 65 ° C. for 10 minutes, and stored at 4 ° C. Transscriptor High Fidelity Reverse
<比較例3>
実施例1で作製した破砕液に代え、比較例1の破砕液を用いた以外は、実施例2と同様の手順により、RNAを抽出し、PCRのサイクル数をカウントした。
<Comparative Example 3>
RNA was extracted and the number of PCR cycles was counted by the same procedure as in Example 2 except that the disrupted solution of Comparative Example 1 was used instead of the disrupted solution prepared in Example 1.
<比較例4>
実施例1で作製した破砕液に代え、比較例2の破砕液を用いた以外は、実施例2と同様の手順により、RNAを抽出し、PCRのサイクル数をカウントした。
<Comparative example 4>
RNA was extracted and the number of PCR cycles was counted by the same procedure as in Example 2 except that the disrupted solution of Comparative Example 2 was used instead of the disrupted solution prepared in Example 1.
<比較例5>
実施例1で作製した破砕液に代え、Qiagen社のmiRNeasy Miniに付属しているQIAzol Lysis Reagentを700μL添加し、化学的にHela細胞を破砕した以外は、実施例2と同様の手順により、RNAを抽出し、PCRのサイクル数をカウントした。
<Comparative Example 5>
Instead of the disruption solution prepared in Example 1, 700 μL of QIAzol Lysis Reagent attached to miRNeasy Mini of Qiagen was added, and the procedure was the same as in Example 2 except that Hela cells were chemically disrupted. Was extracted and the number of PCR cycles was counted.
図4は、実施例2及び比較例3~5の撹拌時間とサイクル数の関係を示すグラフである。図4から明らかなように、化学的にHela細胞を破砕した比較例5では、撹拌時間に関係なく、ほぼ同じサイクル数となった。一方、ナノワイヤ4を分散した破砕液を用いた実施例2では、撹拌時間が60分程度までは、比較例3及び4と大差は見られなかったが、撹拌時間を長くするに従い、サイクル数は明らかに小さくなった。以上の結果より、本発明のナノワイヤ4を含む破砕液を用いることで、化学的な破砕液を使用することなく、細胞等を破砕し、RNAを抽出できることが明らかとなった。また、撹拌時間を長くすることで、細胞等からより多くのRNAを抽出できることが明らかとなった。
FIG. 4 is a graph showing the relationship between the stirring time of Example 2 and Comparative Examples 3 to 5 and the number of cycles. As is clear from FIG. 4, in Comparative Example 5 in which Hela cells were chemically disrupted, the number of cycles was almost the same regardless of the stirring time. On the other hand, in Example 2 using the crushed liquid in which the
〔RNAの吸着・分解実験〕
次に、懸濁液中に漏出したナノワイヤ4にRNAが吸着するか否か確認を行った。
<実施例3>
実施例1で作製した破砕液700μLに、GAPDHのmRNA溶液(濃度:1,000ng/μL)を10μL加え、VWR社製のボルテックスジェニーを用い、2560rpmで撹拌した。0分、5分、10分、30分、60分、120分間撹拌した懸濁液を全量(710μL)サンプリングした。サンプリングした各懸濁液に対して、Qiagen社のmiRNeasy Miniを用いて、50μLのRNAを抽出した。その後は、実施例2と同様の手順で、蛍光強度が7,000に達するまでのPCRのサイクル数をカウントした。
[RNA adsorption / decomposition experiment]
Next, it was confirmed whether or not RNA was adsorbed on the
<Example 3>
10 μL of GAPDH mRNA solution (concentration: 1,000 ng / μL) was added to 700 μL of the disrupted solution prepared in Example 1, and the mixture was stirred at 2560 rpm using a VWR vortex jenny. The suspensions stirred for 0 minutes, 5 minutes, 10 minutes, 30 minutes, 60 minutes, and 120 minutes were sampled in whole volume (710 μL). 50 μL of RNA was extracted from each sampled suspension using Qiagen miRNeasy Mini. Thereafter, the number of PCR cycles until the fluorescence intensity reached 7,000 was counted in the same procedure as in Example 2.
<比較例6>
実施例1で作製した破砕液に代え、比較例1の破砕液を用いた以外は、実施例3と同様の手順により、サイクル数をカウントした。
<Comparative Example 6>
The number of cycles was counted in the same procedure as in Example 3 except that the crushed liquid of Comparative Example 1 was used instead of the crushed liquid produced in Example 1.
<比較例7>
実施例1で作製した破砕液に代え、比較例2の破砕液を用いた以外は、実施例3と同様の手順により、サイクル数をカウントした。
<Comparative Example 7>
The number of cycles was counted in the same procedure as in Example 3 except that the crushed liquid of Comparative Example 2 was used instead of the crushed liquid produced in Example 1.
図5は、実施例3、比較例6及び7の撹拌時間とサイクル数の関係を示すグラフである。図5から明らかなように、比較例6のZnOナノ粒子を含む破砕液の場合には、撹拌時間の増加に伴い、mRNAのサイクル数が増加、つまり、RNAの量が減少した。このことから、撹拌工程の際に、mRNAがZnO粒子に吸着することが分かった。一方、実施例3のナノワイヤ4を含む破砕液及び比較例7のPBS緩衝液のみの場合は、サイクル数はほとんど変化無し、つまり、mRNA量の増減は無かった。以上の結果より、ナノワイヤ4を含んだ破砕液を用いた場合、撹拌工程により懸濁液中に漏出したRNAがナノワイヤ4に吸着したり、分解しないことが分かった。
FIG. 5 is a graph showing the relationship between the stirring time and the number of cycles in Example 3 and Comparative Examples 6 and 7. As is clear from FIG. 5, in the case of the crushed liquid containing the ZnO nanoparticles of Comparative Example 6, the number of cycles of mRNA increased, that is, the amount of RNA decreased as the stirring time increased. From this, it was found that mRNA was adsorbed to ZnO particles during the stirring step. On the other hand, in the case of only the disruption solution containing the
〔クロロホルム添加の影響〕
細胞等から生体分子を化学的破砕方法により抽出する場合、細胞壁や細胞膜を破砕するため、及び、破砕後に生体成分を含む層と分離するために、一般的にクロロホルムを添加する。本発明の破砕液を用いた場合、クロロホルムを添加することなく、細胞等から生体分子を破砕及び抽出できるか否か確認を行った。
[Effect of adding chloroform]
When biomolecules are extracted from cells or the like by a chemical disruption method, chloroform is generally added to disrupt cell walls and cell membranes, and to separate them from layers containing biological components after disruption. When the disruption liquid of the present invention was used, it was confirmed whether biomolecules could be disrupted and extracted from cells or the like without adding chloroform.
<実施例4>
実施例2の手順において、140μLのクロロホルムを添加しなかった以外は、実施例2と同様の手順で、0分及び120分のサンプルの全RNAを抽出し、サイクル数をカウントした。
<Example 4>
In the procedure of Example 2, except that 140 μL of chloroform was not added, the total RNA of the 0 minute and 120 minute samples was extracted in the same procedure as in Example 2, and the number of cycles was counted.
<比較例8>
140μのクロロホルムを添加しなかった以外は、比較例3と同様の手順で0分及び120分のサンプルの全RNAを抽出し、サイクル数をカウントした。
<Comparative Example 8>
Samples of 0 minutes and 120 minutes of total RNA were extracted in the same procedure as Comparative Example 3 except that 140 μ of chloroform was not added, and the number of cycles was counted.
<比較例9>
140μのクロロホルムを添加しなかった以外は、比較例4と同様の手順で0分及び120分のサンプルの全RNAを抽出し、サイクル数をカウントした。
<Comparative Example 9>
Samples of 0 minutes and 120 minutes of total RNA were extracted in the same procedure as in Comparative Example 4 except that 140 µm of chloroform was not added, and the number of cycles was counted.
図6は、実施例4、比較例8及び9、並びに、化学的に細胞等の破砕を行った比較例4の撹拌時間とサイクル数の関係を示すグラフである。図6から明らかなように、クロロホルムを全く添加しなかった実施例4のナノワイヤ4を含む破砕液を用いた場合であっても、120分撹拌後のサイクル数は、比較例4の化学的破砕法のサイクル数に近い値になった。従来の化学的破砕方法では、細胞壁や細胞膜に損傷を与えるためにクロロホルムが必要であったが、その後の分析にクロロホルムは不要であるため、生体分子が含まれる水相画分と相分離して除去する必要があった。一方、本発明の破砕液を用いた場合、ナノワイヤ4で細胞等を破砕した後は、遠心分離によりナノワイヤ4を除去することができるので、相分離を行わなくても効率よく生体分子を抽出することができる。以上の結果より、本発明の破砕液を用いると生体分子に影響を及ぼす可能性のあるクロロホルムを全く使用することなく、細胞等から生体分子を抽出することができることが明らかとなった。
FIG. 6 is a graph showing the relationship between the stirring time and the number of cycles in Example 4, Comparative Examples 8 and 9, and Comparative Example 4 in which cells were chemically disrupted. As is clear from FIG. 6, even when the crushing liquid containing the
〔DNAの抽出・定量実験〕
<実施例5>
〔DNAの抽出〕
実施例2のQiagen社のmiRNeasy Miniに代え、Thermo社のGeneJET Genomic DNA Purification Kitを用い、また、GAPDHのmRNAに代え、GAPDHの発現レベルを指標として、以下の手順でDNAを精製し、PCRのサイクル数をカウントした。
先ず、Hela細胞1×106を遠心分離(250×g、25℃、5分)して上清を捨て、PBSで1回洗浄しペレット状にしたものを、実施例1と同様の手順で作製した破砕液400μLに再懸濁し、0分、5分、10分、30分、60分、120分間ボルテックス(VWR社製のボルテックスジェニーを用い、2,560rpm)をかけた。
次に、20rpm、56℃(hybridization incu.)で10分間撹拌した後、RNase Aを20μL添加し、室温で10分間静置し、250×g、25℃、5分間遠心分離を行い、上澄み400μLを1.5mLチューブに採り、50%ethanol(Wako社製を希釈)を加えボルテックスで撹拌した。次に、付属のスピンカラムに全量を移し、6,000×g、25℃、1分間、遠心分離を行った。その後、新しいコレクションチューブにカラムを付け替え、Wash Buffer Iを500μL入れ、8,000×g、25℃、1分間、遠心処理を行った。ろ液を廃棄し、Wash Buffer IIを500μL入れ、20,000×g、25℃、3分間、遠心分離を行った。1.5mLチューブにカラムを付け替え、Elution Buffer(10mM Tris-HCl、pH.9、0.5mM EDTA)を200μL入れ、2分間室温で静置の後、8,000×g、25℃、1分間、遠心分離を行った。得られた液200μLをDNA抽出サンプルとした。
[DNA extraction and quantification experiments]
<Example 5>
[DNA extraction]
In place of miRNeasy Mini of Qiagen in Example 2, Thermo GeneJET Genomic DNA Purification Kit was used, and instead of GAPDH mRNA, GAPDH expression level was used as an index, DNA was purified by the following procedure, and PCR was performed. The number of cycles was counted.
First, 1 × 10 6 Hela cells were centrifuged (250 × g, 25 ° C., 5 minutes), the supernatant was discarded, and the pellets were washed once with PBS and processed in the same manner as in Example 1. The suspension was resuspended in 400 μL of the prepared disrupted solution, and vortexed (2,560 rpm using a VWR vortex geneny) for 0 minutes, 5 minutes, 10 minutes, 30 minutes, 60 minutes, and 120 minutes.
Next, after stirring at 20 rpm and 56 ° C. (hybridization inc.) For 10 minutes, 20 μL of RNase A was added, allowed to stand at room temperature for 10 minutes, centrifuged at 250 × g, 25 ° C. for 5 minutes, and the supernatant was 400 μL. Was taken in a 1.5 mL tube, 50% ethanol (diluted by Wako) was added and vortexed. Next, the entire amount was transferred to an attached spin column, and centrifuged at 6,000 × g, 25 ° C. for 1 minute. Thereafter, the column was changed to a new collection tube, 500 μL of Wash Buffer I was added, and centrifugation was performed at 8,000 × g, 25 ° C. for 1 minute. The filtrate was discarded, 500 μL of Wash Buffer II was added, and centrifuged at 20,000 × g, 25 ° C. for 3 minutes. Change the column to a 1.5 mL tube, add 200 μL of Elution Buffer (10 mM Tris-HCl, pH.9, 0.5 mM EDTA), let stand at room temperature for 2 minutes, then 8,000 × g, 25 ° C., 1 minute. Centrifugation was performed. 200 μL of the obtained liquid was used as a DNA extraction sample.
〔DNAの定量〕
qPCRは、ロシュ・アプライド・サイエンス社製のLight Cycler Fast Start DNA Master SYBR Green Iを使用した。キットの使用説明書に従い、PCRのサイクルは95℃で10分加熱した後、95℃で10秒、55℃で10秒、72℃で10秒の3つの工程を70サイクル行い、95℃で0秒、55℃で15秒処理し、60℃から95℃までメルティングカーブを描いた後に、40℃で30秒保温し、DNAの定量を行った。DNAの定量は、GAPDHの発現レベルを指標とし、蛍光強度が5000に達するまでのPCRのサイクル数をカウントすることで行った。サイクル数が少ない程、qPCR開始時のDNAの量が多い、つまり、Hela細胞からより多くのDNAを抽出したことを意味する。
[Quantification of DNA]
For qPCR, Light Cycler Fast Start DNA Master SYBR Green I manufactured by Roche Applied Science was used. According to the instructions for use of the kit, the PCR cycle was heated at 95 ° C. for 10 minutes, followed by 70 cycles of 3 steps of 95 ° C. for 10 seconds, 55 ° C. for 10 seconds, and 72 ° C. for 10 seconds. Second, it was treated at 55 ° C. for 15 seconds and a melting curve was drawn from 60 ° C. to 95 ° C., and then kept at 40 ° C. for 30 seconds to quantify DNA. DNA was quantified by counting the number of PCR cycles until the fluorescence intensity reached 5000 using the expression level of GAPDH as an index. The smaller the number of cycles, the greater the amount of DNA at the start of qPCR, that is, more DNA was extracted from Hela cells.
<比較例10>
実施例1で作製した破砕液に代え、比較例1の破砕液を400μL用いた以外は、実施例5と同様の手順により、サイクル数をカウントした。
<Comparative Example 10>
The number of cycles was counted in the same procedure as in Example 5, except that 400 μL of the crushed liquid of Comparative Example 1 was used instead of the crushed liquid produced in Example 1.
<比較例11>
実施例1で作製した破砕液に代え、比較例2の破砕液を400μL用いた以外は、実施例5と同様の手順により、サイクル数をカウントした。
<Comparative Example 11>
The number of cycles was counted in the same procedure as in Example 5 except that 400 μL of the crushed liquid of Comparative Example 2 was used instead of the crushed liquid prepared in Example 1.
<比較例12>
実施例1で作製した破砕液に代え、Thermo社製のGeneJET Genomic DNA Purification Kitを用いて化学的にHela細胞を破砕した以外は、実施例5と同様の手順により、サイクル数をカウントした。
<Comparative Example 12>
The number of cycles was counted in the same procedure as in Example 5 except that Hela cells were chemically disrupted using the GeneJET Genomic DNA Purification Kit manufactured by Thermo instead of the disruption solution prepared in Example 1.
図7は、実施例5及び比較例10~12の撹拌時間とサイクル数の関係を示すグラフである。図7から明らかなように、ナノワイヤ4を分散した破砕液を用いた実施例5では、撹拌時間とともにDNAの抽出量が多くなり、120分撹拌すると、化学的な破砕液を使用した比較例10よりも多くのDNAを抽出できた。以上の結果より、本発明のナノワイヤ4を含む破砕液を用いることで、化学的な破砕液を使用することなく、細胞等からDNAを抽出できることが明らかとなった。
FIG. 7 is a graph showing the relationship between the stirring time of Example 5 and Comparative Examples 10 to 12 and the number of cycles. As is clear from FIG. 7, in Example 5 using the crushing liquid in which
次に、Protease Kを固定化したナノワイヤ4を含む破砕液を作製し、撹拌工程時に、懸濁液中のタンパク質を分解できるか否か確認を行った。
Next, a crushed
<実施例6>
〔Protease Kを固定したナノワイヤ4を含む破砕液の作製〕
実施例1の吸光度を0.630にしたナノワイヤ4を含む破砕液を、Protease K溶液(Thermo社製のGeneJET Genomic DNA Purification Kit)に混合して10分間放置した後、エッペンドルフ社製の5424Rを用いて1,000rpmで3分間遠心分離し、上澄みを400μL採り、PBS緩衝液を400μL加えることで、Protease Kを固定したナノワイヤ4を含む破砕液を作製した。
<Example 6>
[Preparation of crushing
The crushing
<実施例7>
〔Protease Kを固定したナノワイヤ4を用いた破砕実験〕
実施例1で作製した破砕液に代え、実施例6で作製した破砕液を用いた以外は、実施例2と同様の手順で120分撹拌した懸濁液のサンプリングを行った。サンプリングした懸濁液は、Thermo社製のGeneJET Genomic DNA Purification Kitを用いてDNAを精製し、分光光度計(NanoDrop(商標登録、株式会社エル・エム・エス社製))を用いてDNA濃度を測定した。
<Example 7>
[Fracture
The suspension stirred for 120 minutes was sampled in the same procedure as in Example 2 except that the crushed liquid produced in Example 6 was used instead of the crushed liquid produced in Example 1. The sampled suspension was purified using a Thermo GeneJET Genomic DNA Purification Kit, and the DNA concentration was measured using a spectrophotometer (NanoDrop (registered trademark, manufactured by LMS Co., Ltd.)). It was measured.
<参考例1>
実施例2の120分間撹拌した懸濁液を、実施例7と同様の手順で測定した。
<Reference Example 1>
The suspension stirred for 120 minutes in Example 2 was measured in the same manner as in Example 7.
図8は、実施例7及び参考例1の分析結果を示す吸光度のチャートである。本チャートは、核酸のピークである260nmとタンパク質のピークである280nmの吸光度の比である260/280が、1.8~2.0はタンパク質が混入していない(pure)ことを示している。また、夾雑物のピークである230nmと260nmの比である260/230が、1.8より大きいと、夾雑物が少ない(pure)ことを示している。図8に示すチャートから明らかなように、Protease Kを固定していない参考例1では、懸濁液中のタンパク質の混合が目立ったが、Protease Kを固定した実施例6においては、タンパク質が分解され、核酸の純度が上昇した。以上の結果より、ナノワイヤ4に酵素を固定化することで、細胞等から漏出した生体分子を撹拌工程中に分解することができ、細胞等を破砕後に、例えば、タンパク質除去工程、又は、核酸除去工程を省略することができる。
FIG. 8 is an absorbance chart showing the analysis results of Example 7 and Reference Example 1. This chart shows that 260/280, which is the ratio of absorbance at 260 nm, which is the peak of nucleic acid, and 280 nm, which is the peak of protein, is 1.8 to 2.0, and no protein is mixed (pure). . In addition, if 260/230, which is the ratio of 230 nm to 260 nm, which is the peak of impurities, is larger than 1.8, it indicates that there are few impurities (pure). As is clear from the chart shown in FIG. 8, in Reference Example 1 in which Protease K was not immobilized, protein mixing in the suspension was conspicuous, but in Example 6 in which Protease K was immobilized, the protein was decomposed. As a result, the purity of the nucleic acid increased. From the above results, by immobilizing the enzyme on the
〔枯草菌の破砕実験〕
次に、サンプルとして枯草菌を用い、ナノワイヤ4の直径を変えた場合の破砕実験を行った。
[Brushing experiment of Bacillus subtilis]
Next, crushing experiments were performed when Bacillus subtilis was used as a sample and the diameter of the
〔破砕液の作製〕
<実施例8>
石英ガラス基板1上(Crystal Base Co.)に、金触媒3をスパッタリングにより厚さ3nm堆積させた。次いで、SnO2を材料に、室温で10Pa、20分間パルスレーザーデポジションを行うことでコアナノワイヤを作製した。次いで、SiO2を材料に、室温で3~4分間スパッタリングを行うことでコアナノワイヤの周りに被覆層を形成した。次に、基板1を1mLのエタノール中に浸漬し、25℃で、超音波装置(US-1、Asone社製)を用いて、38kHz(80W)で約2時間、超音波処理を行うことで、基板1からナノワイヤ4を剥離した。遠心分離によりエタノールを回収し、次いで、500μLのエタノールを用いて2回洗浄し、エタノールを21,130gで1時間遠心分離し、ナノワイヤ4を沈殿させた。上澄みを除去した後、エタノールで再懸濁し、21,130gで1時間遠心分離し、ナノワイヤ4を沈殿させた。上澄みを除去し、バキュームボックス内で乾燥させた。乾燥後のナノワイヤ4を、405nmにおける吸光度(Optical Density;OD)の測定値が0.1となるように水と混合し、20分間超音波処理を行うことでナノワイヤ4を懸濁し、破砕液を作製した。作製した破砕液に含まれるナノワイヤ4の直径は30nm、平均長は2μmであった。
[Preparation of crushing liquid]
<Example 8>
On the quartz glass substrate 1 (Crystal Base Co.), the
<実施例9>
被覆層を形成するためのスパッタリングを、10分とした以外は、実施例8と同様の手順で破砕液を作製した。作製した破砕液に含まれるナノワイヤ4の直径は110nm、平均長は2μmであった。
<Example 9>
A crushed liquid was prepared in the same procedure as in Example 8 except that the sputtering for forming the coating layer was performed for 10 minutes. The
〔サンプルの調整〕
枯草菌(ATCC6633の芽胞液、栄研化学株式会社)を2mLのLB培地に導入し、37℃、125rpmの条件で、5時間培養した。培養液を1mLサンプリングし、25℃、5,000gで10分遠心処理を行うことで菌を沈降させ、上澄みを取り除いた。次に、1mLの10mMリン酸バッファーで菌を再懸濁し、上記と同様の条件で遠心処理を行い、菌を再沈降させることで洗浄処理を行った。この洗浄操作は2回行った。洗浄後の菌体を、OD(584nm)が0.4となるよう、再度10mMリン酸バッファーに懸濁し、サンプルとした。
[Sample adjustment]
Bacillus subtilis (ATCC6633 spore solution, Eiken Chemical Co., Ltd.) was introduced into 2 mL of LB medium and cultured at 37 ° C. and 125 rpm for 5 hours. 1 mL of the culture solution was sampled and centrifuged at 25 ° C. and 5,000 g for 10 minutes to sediment the bacteria, and the supernatant was removed. Next, the bacteria were resuspended with 1 mL of 10 mM phosphate buffer, centrifuged under the same conditions as described above, and washed again by reprecipitation of the bacteria. This washing operation was performed twice. The washed cells were suspended again in 10 mM phosphate buffer so that the OD (584 nm) was 0.4, and used as a sample.
<実施例10>
実施例8で作製した破砕液及び上記〔サンプルの調整〕で作製した枯草菌の懸濁液を5μLずつ混合し、VWR社製のボルテックスジェニーを用い2,560rpmで1時間、撹拌した。図9(1)は撹拌終了時のSEM写真である。撹拌後、5,000gで10分の遠心処理により残渣を除去したのち、分光光度計(NanoDrop(商標登録、株式会社エル・エム・エス社製))を用いて260nmにおける吸光度を測定することで、DNAの定量を行った。
<Example 10>
5 μL each of the disrupted liquid prepared in Example 8 and the Bacillus subtilis suspension prepared in the above [Preparation of Sample] were mixed and stirred at 2,560 rpm for 1 hour using a VWR vortex geneny. FIG. 9 (1) is an SEM photograph at the end of stirring. After stirring, the residue was removed by centrifugation at 5,000 g for 10 minutes, and then the absorbance at 260 nm was measured using a spectrophotometer (NanoDrop (registered trademark, manufactured by LMS Co., Ltd.)). Quantification of DNA was performed.
<実施例11>
実施例9で作製した破砕液を用いた以外は、実施例10と同様の手順により枯草菌を破砕し、DNAの定量を行った。図9(2)は撹拌終了時のSEM写真である。
<Example 11>
The Bacillus subtilis was crushed by the same procedure as in Example 10 except that the crushing solution prepared in Example 9 was used, and DNA was quantified. FIG. 9 (2) is an SEM photograph at the end of stirring.
<比較例13>
ナノワイヤ4を含まない以外は、実施例10と同様の手順により、DNAの定量を行った。図9(3)は撹拌終了時のSEM写真である。
<Comparative Example 13>
DNA was quantified by the same procedure as in Example 10 except that the
図9(1)~(3)のSEM写真から明らかなように、ナノワイヤ4の直径が細い方が、枯草菌を破砕し易いことが確認された。
As is clear from the SEM photographs of FIGS. 9 (1) to 9 (3), it was confirmed that the thinner the
図10は、実施例10及び11、並びに比較例13で求めた懸濁液中のDNA濃度を示す。図10より明らかなように、ナノワイヤ4の直径が細い方が、枯草菌を破砕し易く、その結果、より多くのDNAを抽出できることが確認された。
FIG. 10 shows the DNA concentrations in the suspensions obtained in Examples 10 and 11 and Comparative Example 13. As is clear from FIG. 10, it was confirmed that the
本発明の、ナノワイヤ4を分散した破砕液を用いることで、生体分子に影響を与える化学試薬を用いることなく、細胞等を破砕することができる。したがって、本発明のサンプルの破砕方法、生体分子の抽出方法、及びナノワイヤを含む破砕液は、医療機関、大学、企業、研究機関等において、より正確な生体分子の分析を行うための試料調整に有用である。
By using the crushing liquid in which the
Claims (5)
サンプルを懸濁した破砕液を撹拌する撹拌工程、
を含む、サンプルの破砕方法。 A suspension step of suspending a sample selected from cells, viruses, and fungi in a disruption solution containing nanowires;
A stirring step of stirring the crushed liquid in which the sample is suspended;
A method for crushing a sample.
サンプルを懸濁した破砕液を撹拌する撹拌工程、
撹拌した破砕液を遠心分離して残渣を取り除く残渣除去工程、
を含む、生体分子の抽出方法。 A suspension step of suspending a sample selected from cells, viruses, and fungi in a disruption solution containing nanowires;
A stirring step of stirring the crushed liquid in which the sample is suspended;
A residue removal step of removing the residue by centrifuging the stirred crushed liquid,
A method for extracting biomolecules.
The sample disruption liquid according to claim 4, wherein the nanowire is a nanowire on which one or two selected from a proteolytic enzyme, a ribonuclease, and a deoxyribonuclease are immobilized.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013-268424 | 2013-12-26 | ||
| JP2013268424A JP2017035002A (en) | 2013-12-26 | 2013-12-26 | Sample crushing method, biomolecule extraction method, and crushing liquid containing nanowires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2015098959A1 true WO2015098959A1 (en) | 2015-07-02 |
Family
ID=53478810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2014/084139 Ceased WO2015098959A1 (en) | 2013-12-26 | 2014-12-24 | Sample disruption method, biomolecule extraction method, and disruption solution containing nanowires |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2017035002A (en) |
| WO (1) | WO2015098959A1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006067890A (en) * | 2004-09-01 | 2006-03-16 | Shigeji Ikeda | Method for extracting nucleic acid and nucleic acid-extracting kit |
| WO2006123781A1 (en) * | 2005-05-20 | 2006-11-23 | Arkray, Inc. | Methods for recovering microorganism and nucleic acid using fine particle and kit to be used for the methods |
| JP2012080853A (en) * | 2010-10-15 | 2012-04-26 | National Agriculture & Food Research Organization | Method for extracting and purifying acid-resistant bacterial dna |
-
2013
- 2013-12-26 JP JP2013268424A patent/JP2017035002A/en active Pending
-
2014
- 2014-12-24 WO PCT/JP2014/084139 patent/WO2015098959A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006067890A (en) * | 2004-09-01 | 2006-03-16 | Shigeji Ikeda | Method for extracting nucleic acid and nucleic acid-extracting kit |
| WO2006123781A1 (en) * | 2005-05-20 | 2006-11-23 | Arkray, Inc. | Methods for recovering microorganism and nucleic acid using fine particle and kit to be used for the methods |
| JP2012080853A (en) * | 2010-10-15 | 2012-04-26 | National Agriculture & Food Research Organization | Method for extracting and purifying acid-resistant bacterial dna |
Non-Patent Citations (3)
| Title |
|---|
| SHAN Z. ET AL.: "Bacteria capture, lysate clearance, and plasmid DNA extraction using pH-sensitive multifunctional magnetic nanoparticles.", ANALYTICAL BIOCHEMISTRY, vol. 398, 2010, pages 120 - 122 * |
| TAKAO YASUI ET AL.: "Saibo no Butsuriteki Hasai no Tameno Nano Wire Device no Kaihatsu", SOCIETY FOR CHEMISTRY AND MICRO-NANO SYSTEMS DAI 27 KAI KENKYUKAI KOEN YOSHISHU, 23 May 2013 (2013-05-23), pages 28 * |
| YASUI T. ET AL.: "DNA manipulation and separation in sublithographic-scale nanowire array.", ACS NANO, vol. 7, no. 4, 13 March 2013 (2013-03-13), pages 3029 - 3035 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017035002A (en) | 2017-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240392282A1 (en) | Microfluidic device for extracting, isolating, and analyzing dna from cells | |
| CN101082062B (en) | Method for quantifying gene expression in single cell | |
| CN103269787B (en) | Devices and methods for manipulating subject components in tubes | |
| US20140120544A1 (en) | Method and materials for isolation of nucleic acid materials | |
| US20100129878A1 (en) | Methods for nucleic acid amplification | |
| JP2008529516A (en) | Nucleic acid isolation methods including the use of ethylene glycol multimers | |
| JP6684868B2 (en) | One-step method for purification of nucleic acids | |
| JP2008167722A (en) | Nucleic acid isolation method by heating on magnetic support | |
| Lee et al. | Specific rare cell capture using micro-patterned silicon nanowire platform | |
| US20150299769A1 (en) | Method for lysing a fixed biological sample | |
| AU2014265791A1 (en) | Analyte enrichment methods and compositions | |
| JP2007502420A (en) | Sample preparation method and apparatus | |
| Casavant et al. | Efficient sample preparation from complex biological samples using a sliding lid for immobilized droplet extractions | |
| CN101328504A (en) | Massive Parallel Nucleic Acid Analysis Method | |
| JP2018537676A (en) | Integrated sample processing system | |
| TW201903147A (en) | Method and apparatus for extracting nucleic acid | |
| US20180282786A1 (en) | Methods and apparatus for selective nucleic acid separation | |
| US11701668B1 (en) | Methods and devices for magnetic separation | |
| WO2018134907A1 (en) | Device and method for extracting multiple biomolecules from single cell | |
| JPWO2014065192A1 (en) | Nucleic acid extraction device, method for producing the device, nucleic acid extraction method and nucleic acid sequence analysis method | |
| WO2015098959A1 (en) | Sample disruption method, biomolecule extraction method, and disruption solution containing nanowires | |
| JP2019024453A (en) | RNA concentration determination method, RNA concentration determination device, and RNA concentration determination device | |
| US20240401022A1 (en) | Devices, methods, and systems for extracting genomic dna from cell samples with tunable size selection | |
| US20210363561A1 (en) | Method of enrichment of micro-organisms in whole blood | |
| US20240301397A1 (en) | Systems and methods for capture of circulating free dna |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14873706 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14873706 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |